PRGO : Summary for Perrigo Company plc Ordinary Sh - Yahoo Finance

U.S. Markets closed

Perrigo Company plc (PRGO)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
84.47+1.35 (+1.62%)
At close: 4:01PM EST
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close83.12
Bid0.00 x
Ask0.00 x
Day's Range82.54 - 84.64
52 Week Range71.84 - 140.65
Avg. Volume1,640,031
Market Cap12.11B
PE Ratio (TTM)-8.38
Earnings DateN/A
Dividend & Yield0.58 (0.69%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire2 days ago

    Perrigo Announces FDA Final Approval For Hydrocodone Bitartrate And Homatropine Methylbromide Oral Solution

    DUBLIN, Feb. 17, 2017 /PRNewswire/ -- Perrigo Company plc (NYSE, TASE: PRGO) today announced it has received final approval from the U.S. Food and Drug Administration for hydrocodone bitartrate and homatropine methylbromide oral solution (syrup), 5 mg/1.5 mg per 5 mL. Hydrocodone bitartrate and homatropine methylbromide oral solution (syrup), 5 mg/1.5 mg per 5 mL is indicated for the symptomatic relief of cough in adults and children 6 years of age and older. Perrigo CEO John T. Hendrickson stated, "This final approval is another example of Perrigo's ongoing commitment to developing high quality value alternatives in important treatment categories.

  • PR Newswire5 days ago

    Perrigo To Release Fourth Quarter And Calendar Year 2016 Results On February 27, 2017

    DUBLIN, Feb. 14, 2017 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced that it will release financial results for its fourth quarter and calendar year 2016 on Monday, February 27, ...

  • Investopedia6 days ago

    Starboard Value's Jeff Smith Wins Five Perrigo Board Seats

    Jeff Smith, the activist investor, has clenched five seats on the drug manufacturer's board of directors and a spot on two different strategic committees.